Studies have found that Betulinic acid can down-regulate the expression of Vasodilator-stimulated phosphoprotein by inhibiting signal transduction of the NF-κB pathway, thereby inhibiting the proliferation and migration of GC cells and achieving the effect of treating PLGC (24). This evidence concerns the gene NFKB1 and gastric cancer.